February 27, 2020 / 11:20 PM / a month ago

BRIEF-Apellis Pharmaceuticals Reports Qtrly Net Loss Of $1.77 Per Share

Feb 27 (Reuters) - Apellis Pharmaceuticals Inc:

* APELLIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* APELLIS PHARMACEUTICALS INC QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $1.77 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below